RISPERDAL M-TAB
Drug timelines are a Plus or Pro feature.
20 regulatory and trial events tracked for RISPERDAL M-TAB, covering 2006-10-06 to 2025-01-22. Get the full timeline:
Most recent: FDA Approved: RISPERDAL M-TAB — Supplemental Application (Janssen Pharmaceuticals, Inc.)